Qube Research & Technologies (QRT)
AGRX

Qube Research & Technologies (QRT)’s Agile Therapeutics AGRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$11K – 3121
2021
Q3 		$11K Hold
6
– – ﹤0.01% 2035
2021
Q2 		$16K Buy
+6
New +$19.8K ﹤0.01% 2115
2020
Q3 		– Sell
-28
Closed -$158K – 2220
2020
Q2 		$158K Sell
28
-17
-38% -$88.3K ﹤0.01% 1459
2020
Q1 		$166K Sell
45
-61
-58% -$350K 0.01% 904
2019
Q4 		$529K Buy
+106
New +$370K 0.02% 921

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return